The blue-chip board and the startup star had been on a collision course for months. Here’s what really happened.

The company’s valuation had dropped from $6 billion in 2021, to under $150 million after going public and when CEO Anne Wojcicki pushed for a plan to buy it and take it private, the board rejected her ...

Financial and security chaos at the once-pioneering genetic testing firm has intensified concerns about user data. Here's how ...

Anne Wojcicki, the CEO of the consumer genetic testing company 23andMe (ME), is cautiously optimistic about the firm’s future ...

In 2009, Anne Wojcicki took a decisive step in her role as the leader of 23andMe, the genetic testing company she co-founded ...

23andMe, named because of the number of chromosome pairs in human DNA, raised more than $1.1bn before its hotly awaited IPO ...

Anne Wojcicki, CEO of 23andMe, the struggling DNA testing company, doesn’t think this is the right time to examine her ...

Since it was founded nearly two decades ago, 23andMe has grown into one of the largest biotechnology companies in the world.

But I still remember the first moment I met 23andMe CEO and co-founder Anne Wojcicki in 2007. My editor at the time had set up a meeting between my reporting partner and I and Wojcicki ...

Anne Wojcicki's latest move puts her and the company right back to where they were in April. From the San Francisco Business Times. Anne Wojcicki, the cofounder and CEO of 23andMe, now says her ...

From the San Francisco Business Times. Anne Wojcicki, the cofounder and CEO of 23andMe, now says her plan to take the genetic testing company private is its "the best path forward." Wojcicki ...